| Identification | Back Directory | [Name]
4,6-Diamino-1-(2-deoxy-b-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine | [CAS]
117818-23-2 | [Synonyms]
2-Amino-8-aza-7-deoxy-2'-deoxyadenosine
2-Amino-8-aza-7-deoxy-2’-deoxyadenosine
4,6-Diamino-1-(2-deoxy--D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine
4,6-Diamino-1-(2-deoxy-b-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine
1H-Pyrazolo[3,4-d]pyrimidine-4,6-diamine, 1-(2-deoxy-β-D-erythro-pentofuranosyl)- | [Molecular Formula]
C10H14N6O3 | [MDL Number]
MFCD30570219 | [MOL File]
117818-23-2.mol | [Molecular Weight]
266.257 |
| Hazard Information | Back Directory | [Uses]
4,6-Diamino-1-(2-deoxy-beta-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine is a pyrimidine nucleoside analog. Pyrimidine nucleoside analogs have a wide range of biochemical and anticancer activities. These include DNA synthesis inhibition, RNA synthesis inhibition, antiviral effects, and immunomodulatory effects[1]. | [References]
[1] Galmarini CM, et al. Pyrimidine nucleoside analogs in cancer treatment. Expert Rev Anticancer Ther. 2003 Oct;3(5):717-28. DOI:10.1586/14737140.3.5.717 |
|
|